Stories / Global Impact

A novel therapy may free some transplant patients from having to take immunosuppressant drugs for...

Stories / Hope

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's...

Stories / Global Impact

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to...

Explore Novartis

Recent Updates

Featured / 20 Aug

Novartis recognized for innovative social business ventures

Novartis ranks #9 on Fortune magazine’s “Change the World” list of companies that are doing well by doing good. 

European Commission approves #Novartis drug for previously treated #multiplemyeloma based on pivotal Phase III data http://t.co/OOYPe4V0yR 16 min 43 sec ago
Our Business

Novartis focuses its business on three leading divisions with strong innovation power and global scale: pharmaceuticals, eye care and generics.